ofloxacin has been researched along with Diathesis in 9 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Excerpt | Relevance | Reference |
---|---|---|
"5 g piperacillin/tazobactam 3 times a day in patients with low-risk febrile neutropenia." | 9.11 | Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia. ( Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T, 2004) |
"Levofloxacin was administered and 3 days later, he complained of pain in the left Achilles tendon and revealed redness and swelling in the area." | 5.36 | Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions. ( Baek, YS; Cheong, MH; Durey, A; Lee, JS; Lee, K; Park, JS; Ryu, JS, 2010) |
"5 g piperacillin/tazobactam 3 times a day in patients with low-risk febrile neutropenia." | 5.11 | Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia. ( Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T, 2004) |
"Levofloxacin was administered and 3 days later, he complained of pain in the left Achilles tendon and revealed redness and swelling in the area." | 1.36 | Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions. ( Baek, YS; Cheong, MH; Durey, A; Lee, JS; Lee, K; Park, JS; Ryu, JS, 2010) |
"Bacterial prostatitis is documented at a very low prevalence (7-13% of prostatitis overall considered) due to either reduced utilization of viral and bacteriological tests (Meares test, urethral swab, bacterial and viral PCR) or to the possibility that individual patients show a scarce expression of bacterial disease in biological fluids, because of intraglandular biofilm presence, with subsequent spreading of the sole plankton microrganisms." | 1.35 | [Chronic prostatitis and biofilm]. ( Bartoletti, R; Cai, T, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (77.78) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartoletti, R | 1 |
Cai, T | 1 |
Durey, A | 1 |
Baek, YS | 1 |
Park, JS | 1 |
Lee, K | 1 |
Ryu, JS | 1 |
Lee, JS | 1 |
Cheong, MH | 1 |
Blasi, F | 1 |
Metterlein, T | 1 |
Schuster, F | 1 |
Tadda, L | 1 |
Hager, M | 1 |
Muldoon, S | 1 |
Capacchione, J | 1 |
Roewer, N | 1 |
Anetseder, M | 1 |
Candel, FJ | 1 |
López, R | 1 |
Valdivia, A | 1 |
Núñez, MJ | 1 |
Roca-Arbonés, V | 1 |
Picazo de la Garza, JJ | 1 |
Donzella, JG | 1 |
Merrick, GS | 1 |
Lindert, DJ | 1 |
Andreini, HJ | 1 |
Curtis, RL | 1 |
Luna, IH | 1 |
Allen, Z | 1 |
Butler, WM | 1 |
Cornely, OA | 1 |
Wicke, T | 1 |
Seifert, H | 1 |
Bethe, U | 1 |
Schwonzen, M | 1 |
Reichert, D | 1 |
Ullmann, AJ | 1 |
Karthaus, M | 1 |
Breuer, K | 1 |
Salzberger, B | 1 |
Diehl, V | 1 |
Fätkenheuer, G | 1 |
Norazah, A | 1 |
Lim, VK | 1 |
Rohani, MY | 1 |
Kamel, AG | 1 |
Trinchieri, A | 1 |
Mangiarotti, B | 1 |
Lizzano, R | 1 |
3 reviews available for ofloxacin and Diathesis
Article | Year |
---|---|
[Therapeutic experience with levofloxacin in pneumonia and COPD].
Topics: Algorithms; Anti-Bacterial Agents; Clinical Trials as Topic; Community-Acquired Infections; Cross In | 2009 |
[Endocarditis due to Stenotrophomonas maltophilia].
Topics: Aortic Valve Insufficiency; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Thera | 2002 |
[Use of levofloxacin in the antibiotic prophylaxis for diagnostic procedures in urology].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinar | 2002 |
1 trial available for ofloxacin and Diathesis
Article | Year |
---|---|
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibili | 2004 |
5 other studies available for ofloxacin and Diathesis
Article | Year |
---|---|
[Chronic prostatitis and biofilm].
Topics: Adult; Biofilms; Chronic Disease; Ciprofloxacin; Contraception Behavior; Diet; Disease Susceptibilit | 2009 |
Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions.
Topics: Achilles Tendon; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Disease Susceptibility | 2010 |
Fluoroquinolones influence the intracellular calcium handling in individuals susceptible to malignant hyperthermia.
Topics: Animals; Calcium; Ciprofloxacin; Disease Susceptibility; Fluoroquinolones; Levofloxacin; Malignant H | 2011 |
Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxaci | 2004 |
In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Topics: Anti-Bacterial Agents; Aza Compounds; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; | 2005 |